Rajesh Kumar
Stock Analyst at HSBC
(2.80)
# 1,705
Out of 5,124 analysts
29
Total ratings
52.63%
Success rate
7.68%
Average return
Main Sectors:
Stocks Rated by Rajesh Kumar
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BIIB Biogen | Downgrades: Reduce | $144 → $143 | $175.99 | -18.75% | 1 | Dec 10, 2025 | |
| ABBV AbbVie | Upgrades: Buy | $225 → $265 | $228.49 | +15.98% | 5 | Dec 10, 2025 | |
| NVO Novo Nordisk | Downgrades: Hold | n/a | $50.88 | - | 3 | Nov 24, 2025 | |
| IQV IQVIA Holdings | Upgrades: Buy | $195 → $235 | $225.41 | +4.25% | 2 | Oct 9, 2025 | |
| LLY Eli Lilly and Company | Upgrades: Hold | $675 → $700 | $1,074.68 | -34.86% | 3 | Aug 27, 2025 | |
| KDP Keurig Dr Pepper | Upgrades: Buy | $36 → $42 | $28.01 | +49.95% | 1 | Apr 25, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Buy | $660 → $670 | $579.45 | +15.63% | 3 | Apr 30, 2024 | |
| DHR Danaher | Upgrades: Buy | $250 → $280 | $228.92 | +22.31% | 2 | Apr 17, 2024 | |
| UNH UnitedHealth Group | Upgrades: Hold | $460 | $330.11 | +39.35% | 2 | Apr 4, 2024 | |
| TEVA Teva Pharmaceutical Industries | Initiates: Buy | $13 | $31.21 | -58.35% | 1 | Dec 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Hold | $55 → $53 | $53.94 | -1.74% | 2 | Oct 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Reduce | $97 | $29.49 | +228.93% | 1 | Jul 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $124 | $95.20 | +30.25% | 1 | Jul 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $50 | $24.90 | +100.80% | 1 | Jul 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $123 | $105.26 | +16.85% | 1 | Jul 14, 2023 |
Biogen
Dec 10, 2025
Downgrades: Reduce
Price Target: $144 → $143
Current: $175.99
Upside: -18.75%
AbbVie
Dec 10, 2025
Upgrades: Buy
Price Target: $225 → $265
Current: $228.49
Upside: +15.98%
Novo Nordisk
Nov 24, 2025
Downgrades: Hold
Price Target: n/a
Current: $50.88
Upside: -
IQVIA Holdings
Oct 9, 2025
Upgrades: Buy
Price Target: $195 → $235
Current: $225.41
Upside: +4.25%
Eli Lilly and Company
Aug 27, 2025
Upgrades: Hold
Price Target: $675 → $700
Current: $1,074.68
Upside: -34.86%
Keurig Dr Pepper
Apr 25, 2025
Upgrades: Buy
Price Target: $36 → $42
Current: $28.01
Upside: +49.95%
Thermo Fisher Scientific
Apr 30, 2024
Maintains: Buy
Price Target: $660 → $670
Current: $579.45
Upside: +15.63%
Danaher
Apr 17, 2024
Upgrades: Buy
Price Target: $250 → $280
Current: $228.92
Upside: +22.31%
UnitedHealth Group
Apr 4, 2024
Upgrades: Hold
Price Target: $460
Current: $330.11
Upside: +39.35%
Teva Pharmaceutical Industries
Dec 18, 2023
Initiates: Buy
Price Target: $13
Current: $31.21
Upside: -58.35%
Oct 27, 2023
Upgrades: Hold
Price Target: $55 → $53
Current: $53.94
Upside: -1.74%
Jul 14, 2023
Initiates: Reduce
Price Target: $97
Current: $29.49
Upside: +228.93%
Jul 14, 2023
Initiates: Buy
Price Target: $124
Current: $95.20
Upside: +30.25%
Jul 14, 2023
Initiates: Buy
Price Target: $50
Current: $24.90
Upside: +100.80%
Jul 14, 2023
Initiates: Hold
Price Target: $123
Current: $105.26
Upside: +16.85%